Phase III Farletuzumab Trial Fails to Meet Endpoints in Platinum-Sensitive Disease May 02, 2016Vol.- No.-
Study: Reolysin-Paclitaxel Combination Demonstrates Higher Response than Paclitaxel Therapy Alone March 31, 2016Vol.39 No.03
Atezolizumab Immunotherapy Boosts OS Compared to Docetaxel in Phase II Trial March 31, 2016Vol.39 No.03
Vyxeos Injection Improves Overall Survival in Phase III Acute Myeloid Leukemia Trial March 31, 2016Vol.39 No.03
